XNYS · EW

-1.01% · -$0.8700 · Vol 382.6K

Live · updated 10:37:36 ET

Edwards Lifesciences Corp

ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES

$85.52

Card

Relationship Map

Follow $EW

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $EW by email

Veridion Score

BETAHIGH CONF · 6 of 6 factors measured

Mon Oct 12 · last completed session · daily score · 18h old · EW

Methodology

Edwards Lifesciences Corp

Mon Oct 12 · last completed session · daily score · 18h old

57/100

Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

57/ 100

Veridion Score

Middle range · HIGH confidence · 6 of 6 factors measured

Sovereign · $25/mo

See why this score moved.

· Factor breakdown with raw signals
· Day-over-day delta + driver
· Factor coverage readout
· Valuation · hype · market flow
· Pro Chart event markers
· Score history + alerts

Start Sovereign · $25/mo →or $250/yr

Cancel anytime · or Reserve · $79/mo or $790/yr

Confidence: HIGH · 6 of 6 factors measured · Mon Oct 12 · last completed session · daily score · 18h old

Share on X →

AI Analysis

Sovereign

Why is EW moving today?

Sovereign unlock connects news, insider activity, analyst moves, and available price action.

Catalyst calendar

What can move EW next.

Earnings, ratings, disclosures, volume, and score-history events. Every row needs a dated receipt.

Congress

Upcoming

No dated upcoming catalyst is present in the current source window.

Recent

Mar 27
Congress
Alan Armstrong purchase disclosed
STOCK Act filing
Nov 19
Congress
Josh Gottheimer sale disclosed
STOCK Act filing
May 12
Congress
Jefferson Shreve sale disclosed
STOCK Act filing
Apr 21
Congress
Bruce Westerman sale disclosed
STOCK Act filing
Apr 8
Congress
Robert P. Bresnahan, Jr. purchase disclosed
STOCK Act filing
Apr 7
Congress
Jefferson Shreve purchase disclosed
STOCK Act filing
Mar 3
Congress
Bruce Westerman purchase disclosed
STOCK Act filing
Aug 20
Congress
Markwayne Mullin sale disclosed
STOCK Act filing

About Edwards Lifesciences Corp

ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES

Listed since

2000

Employees

16K

Country

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Company website →

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open

$86.55

Day high

$86.77

Day low

$85.36

Previous close

$86.39

52W high

$95.18

-10.15% from high

52W low

$72.65

57% of range

Market cap

$49.8B

Beta

0.21

Shares out

576.4M

Volume

382.6K

0.11× rel vol

Avg volume

3.5M

VWAP

$85.84

Price history computed in-house

-1.11%

+1.36%

-2.01%

+17.23%

YTD

+0.32%

SMA 50 $88.63 · below

SMA 200 $85.14 · above

52W position 57%

EW overview

Veridion Score

Registered · 2026-10-12

6 of 6 factors measured

Latest receipt rows

Josh Gottheimer · Sale

13F holders

None on file

Relationship mapTrace receipt-backed holders and filings around EW.Congress disclosuresOpen receipt and filing context for EW.MethodologyReview score inputs, coverage rules, and limitations.

SEC Form 4 ledger

EW insider activity

Edwards Lifesciences Corp

90 days, by filing date. Issuer coverage time not measured. Published Oct 12, 2026, 4:32 PM EDT.

Score

Not evaluated

Pressure

Not evaluated

Transactions

Not measured

Filings

Not measured

Buys / sells

Not measured

Net value

Not evaluated

Insiders

Not measured

Cluster

Not covered: this ticker is outside our Form 4 ingest scope — we have not looked

Net pressure

Not evaluated: no value-bearing Form 4 rows are loaded.

Convergence not evaluated

No value-bearing Form 4 rows are loaded, so cross-source convergence is not evaluated.

Form 4 evidence state

Not covered: this ticker is outside our Form 4 ingest scope — we have not looked.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology

Public disclosures

Congress activity in EW

Congress tracker Open ticker disclosure ledger →

17 filers · 17 buys · 17 sells (1 labeled S (partial)) · Feb 14, 2014 to Mar 27, 2026 · House 28 / Senate 6

All available history · Latest 5 of 34 lines · Read Oct 13, 2026, 2:37 PM UTC

Josh GottheimerSelljoint

Edwards Lifesciences Corporation Common Stock · Transaction Nov 19, 2025 · Filed Dec 29, 2025 · $1,001 to $15,000

Official filing ↗

Jefferson ShreveSell

Edwards Lifesciences Corporation Common Stock · Transaction May 12, 2025 · Filed Jun 22, 2025 · $50,001 to $100,000

Official filing ↗

Bruce WestermanSell

Edwards Lifesciences Corporation Common Stock · Transaction Apr 21, 2025 · Filed May 12, 2025 · $1,001 to $15,000

Official filing ↗

Markwayne MullinS (partial)joint

Edwards Lifesciences Corp · Transaction Aug 20, 2024 · Filed Sep 19, 2024 · $15,001 to $50,000

Official filing ↗

Markwayne MullinBuyjoint

Edwards Lifesciences Corporation Common Stock · Transaction Oct 3, 2023 · Filed Nov 1, 2023 · $1,001 to $15,000

Official filing ↗

See all 34 trades, filters and CSV — Sovereign $25/mo

Federal contracts

EW contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed

Refresh interval: 12hSource: Federal contract awards

No federal contracts on file for EW in this window.

Lobbying spend

EW lobbying filings, year to date.

Registered lobbying filings matched to Edwards Lifesciences Corp.

$1.1M

Refresh interval: 12hSource: LDA disclosure filings

Health Issues Medicare/Medicaid Trade (domestic/foreign)Health Issues

Filing

$350.0K

EDWARDS LIFESCIENCES LLC

EDWARDS LIFESCIENCES, LLC

Jan 20, 2026

Filing

$340.0K

EDWARDS LIFESCIENCES LLC

EDWARDS LIFESCIENCES, LLC

Apr 20, 2026

Filing

$280.0K

EDWARDS LIFESCIENCES LLC

EDWARDS LIFESCIENCES, LLC

Jul 20, 2026

Analyst ratings

Sovereign unlock shows available analyst consensus for EW.

Related tickers

Cross-references from this score page.

Apprentice · 1 rail

Similar headline score

Nearest public composite scores. Factor similarity requires Sovereign.

Follow $EW

Why is EW moving today?

What can move EW next.

EW overview

Related filings and maps

EW insider activity

EW contract awards, year to date.

EW lobbying filings, year to date.

Cross-references from this score page.

What can move EW next.

EW insider activity

Cross-references from this score page.